7/102 sources · 2 publishersUpdated Nov 5, 12:15 UTC
Aurora Cannabis posts Q2 2027 results and announces pending Organigram acquisition
Aurora Cannabis reported fiscal Q2 2027 net revenue of C$86.0 million. Adjusted EBITDA was about C$14 million and adjusted net income was roughly C$3.1 million. The company disclosed that Organigram will acquire all Aurora shares, with a shareholder meeting slated for December 2026 and the transaction expected to close in January 2027.
Why it matters
The pending acquisition will transfer ownership of Aurora to Organigram, potentially affecting share value and governance once the deal closes, as noted by the company’s statement that the transaction is the next major catalyst.
Key facts
- 1Net revenue for Q2 2027 was C$86.0 million. stocktitan.net
- 2Adjusted EBITDA for the quarter was C$13.997 million (rounded to C$14.0 million). stocktitan.net
- 3Adjusted net income for the quarter was C$3.106 million (rounded to C$3.1 million). stocktitan.net
- 4Aurora held cash and cash equivalents of C$133.0 million and had no debt. stocktitan.net
- 5Organigram will acquire all Aurora common shares in a definitive agreement. stocktitan.net
- 6A special shareholders’ meeting to approve the transaction is expected in December 2026, and the deal is expected to close in January 2027, subject to approvals. tradingview.com
Open questions
- YoY net revenue increase is reported as 44% and 9%; the discrepancy is noted.
Summary written by AlphAI AI Desk from 2 of 2 sources. Not investment advice. Figures are as stated by the linked sources.